Pacira BioSciences (PCRX) Operating Expenses (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Operating Expenses of $170.5 million for Q1 2026, up 2.12% year-over-year from $166.9 million in Q1 2025, and down 12.37% quarter-over-quarter from $194.5 million in Q4 2025.
Pacira BioSciences (PCRX) Operating Expenses (2010 - 2026) Analysis & Trends
Pacira BioSciences' Operating Expenses history runs 17 years deep, the most recent figure standing at $170.5 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 2.12% year-over-year to $170.5 million; the TTM figure through Mar 2026 stood at $710.8 million (down 9.73% YoY), while the FY2025 annual figure was $707.2 million, down 8.67% from the prior year.
- Operating Expenses for Q1 2026 stood at $170.5 million, down from $194.5 million in the prior quarter.
- The five-year high for Operating Expenses was $308.1 million in Q3 2024, with the low at $129.6 million in Q2 2023.
- The 5-year median for Operating Expenses is $162.5 million (2024), against an average of $167.4 million.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 110.73% in 2024, then slumped 43.8% in 2025.
- Pacira BioSciences' Operating Expenses stood at $181.8 million in 2022, then slipped by 18.57% to $148.1 million in 2023, then climbed by 9.77% to $162.5 million in 2024, then gained by 19.68% to $194.5 million in 2025, then dropped by 12.37% to $170.5 million in 2026.
- Business Quant data shows PCRX's Operating Expenses at $170.5 million in Q1 2026, $194.5 million in Q4 2025, and $173.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Pacira BioSciences | 943.93 Mn | 692.90 Mn | 148.24 Mn | 188.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 188.13 Mn |
| Mar 31, 2026 | 170.47 Mn |
| Dec 31, 2025 | 194.53 Mn |
| Sep 30, 2025 | 173.15 Mn |
| Jun 30, 2025 | 172.60 Mn |
| Mar 31, 2025 | 166.93 Mn |
| Dec 31, 2024 | 162.55 Mn |
| Sep 30, 2024 | 308.10 Mn |
| Jun 30, 2024 | 149.78 Mn |
| Mar 31, 2024 | 153.91 Mn |
| Dec 31, 2023 | 148.08 Mn |
| Sep 30, 2023 | 146.21 Mn |
| Jun 30, 2023 | 129.59 Mn |
| Mar 31, 2023 | 163.43 Mn |
| Dec 31, 2022 | 181.85 Mn |
| Sep 30, 2022 | 146.18 Mn |
| Jun 30, 2022 | 138.18 Mn |
| Mar 31, 2022 | 140.60 Mn |
| Dec 31, 2021 | 154.98 Mn |
| Sep 30, 2021 | 96.29 Mn |